Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12226
Abstract: Abstract Background Cold urticaria (ColdU) is characterized by pruritic wheals following exposure of the skin to cold. Many patients show insufficient response to antihistamines, the first line treatment. Based on the high efficacy of interleukin‐1(IL‐1)‐inhibition… read more here.
Keywords: inhibition; placebo; rilonacept; cold urticaria ... See more keywords
JAAD Game Changers: Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.11.004
Abstract: Acquired cold urticaria (ACU) is characterized by the development of wheals, angioedema, or both after cold exposure. Age at diagnosis, disease severity, and response to the ice cube challenge test predicted both prognosis and response… read more here.
Keywords: jaad game; cold urticaria; urticaria clinical; game changers ... See more keywords
Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.14081
Abstract: Dupilumab is a human monoclonal IgG4 antibody that inhibits IL-4 and IL-13 signalling by binding specifically to the IL-4Rα subunit, shared by both the IL4 and IL-13 receptor complexes (1) recently introduced for the treatment… read more here.
Keywords: severe atopic; treatment; cold urticaria; atopic dermatitis ... See more keywords
A case of Bazex syndrome with type 2 immune response
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2022.4325
Abstract: 641 1. Maltseva N, Borzova E, Fomina D, et al. Cold urticaria What we know and what we do not know. Allergy 2021; 76: 1077-94. 2. EMA. Xolair. European Medicines Agency, 2018. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/xolair… read more here.
Keywords: allergy; cold urticaria; clin immunol; allergy clin ... See more keywords